BIOMAT Database Logo BIOMAT Database Logo

Comparison of efficacy, safety, and tolerability of Neoral vs Sandimmun in de novo renal transplant patients over 24 months' treatment. 1997

D Abendroth, and B Buchholz, and W Land, and G May, and M Wiesel, and L Färber, and A Korn, and A Maibücher
Sandoz AG, Nürnberg.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005858 Germany A country in central Europe, bordering the Baltic Sea and the North Sea, between the Netherlands and Poland, south of Denmark. The capital is Berlin.
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014508 Urea A compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids. Basodexan,Carbamide,Carmol
D014527 Uric Acid An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN. 2,6,8-Trihydroxypurine,Ammonium Acid Urate,Monosodium Urate,Monosodium Urate Monohydrate,Potassium Urate,Sodium Acid Urate,Sodium Acid Urate Monohydrate,Sodium Urate,Sodium Urate Monohydrate,Trioxopurine,Urate,Acid Urate, Ammonium,Acid Urate, Sodium,Acid, Uric,Monohydrate, Monosodium Urate,Monohydrate, Sodium Urate,Urate Monohydrate, Monosodium,Urate Monohydrate, Sodium,Urate, Ammonium Acid,Urate, Monosodium,Urate, Potassium,Urate, Sodium,Urate, Sodium Acid

Related Publications

D Abendroth, and B Buchholz, and W Land, and G May, and M Wiesel, and L Färber, and A Korn, and A Maibücher
Safety and tolerability of Sandimmun Neoral vs Sandimmun in de novo renal transplant patients after 24 months' treatment. German Neoral Study Group.
August 1996, Transplantation proceedings,
D Abendroth, and B Buchholz, and W Land, and G May, and M Wiesel, and L Färber, and A Korn, and A Maibücher
Safety and tolerability of CyA microemulsion formulation (Sandimmun Neoral) in stable renal transplant patients after 24 months of treatment. German Neoral Study Group.
August 1996, Transplantation proceedings,
D Abendroth, and B Buchholz, and W Land, and G May, and M Wiesel, and L Färber, and A Korn, and A Maibücher
Long-term experience with Sandimmun Neoral: results in de novo and stable renal transplant patients after 24-month treatment. The German Neoral Study Group.
November 1997, Transplantation proceedings,
D Abendroth, and B Buchholz, and W Land, and G May, and M Wiesel, and L Färber, and A Korn, and A Maibücher
A study to assess the efficacy, tolerability, and safety of a new oral formulation of Sandimmun--Sandimmun Neoral--in stable renal transplant patients.
December 1995, Transplantation proceedings,
D Abendroth, and B Buchholz, and W Land, and G May, and M Wiesel, and L Färber, and A Korn, and A Maibücher
Safety, tolerability, and pharmacokinetics of Sandimmun Neoral: conversion study in stable renal transplant recipients.
June 1996, Transplantation proceedings,
D Abendroth, and B Buchholz, and W Land, and G May, and M Wiesel, and L Färber, and A Korn, and A Maibücher
Use of Sandimmun Neoral in renal transplant patients. International Sandimmun Neoral Study Group.
October 1994, Transplantation proceedings,
D Abendroth, and B Buchholz, and W Land, and G May, and M Wiesel, and L Färber, and A Korn, and A Maibücher
Safety and tolerability of a new oral formulation of cyclosporin A, Sandimmun Neoral, in renal transplant patients.
January 1994, Transplant international : official journal of the European Society for Organ Transplantation,
D Abendroth, and B Buchholz, and W Land, and G May, and M Wiesel, and L Färber, and A Korn, and A Maibücher
Comparison of neoral and sandimmun cyclosporines for de novo lung transplantation in cystic fibrosis patients.
June 1998, Transplantation proceedings,
D Abendroth, and B Buchholz, and W Land, and G May, and M Wiesel, and L Färber, and A Korn, and A Maibücher
Safety and tolerability of conversion from stable Sandimmun maintenance treatment to Sandimmun Neoral in patients with rheumatoid arthritis.
July 1998, The Journal of rheumatology,
D Abendroth, and B Buchholz, and W Land, and G May, and M Wiesel, and L Färber, and A Korn, and A Maibücher
A one-year comparative study of Neoral vs Consupren in de novo renal transplant patients.
November 1998, Transplantation proceedings,
Copied contents to your clipboard!